The role of FABP4 in the pathogenesis of hypertension might be that FABP4 induces the transformation of the insulin-mediated endothelial nitric oxide synthase (eNOS) pathway, thus reducing NO production and endothelial dysfunction [15]. Here, NOS3 is linked to hypertensive disorder.